摘要
目的:观察耳针压丸联合口嚼枸杞子治疗血液透析患者口渴症的临床疗效。方法:选取维持性血液透析且伴口渴症患者50例,给予耳针压丸联合口嚼枸杞子治疗8周。以口干渴强度评分量表评定口渴程度,平均透析间期体重增加相对值评定透析间期体重增长,并探讨口渴强度评分与透析间期体重增加相对值、透析前平均动脉压、透析前血钠浓度的相关性。在治疗前、治疗后4周、8周分别采集透析患者口渴、透析间期体重、透前血压及透前血钠的变化。结果:50例患者治疗2个疗程后,口干渴强度评分较治疗前均有显著下降(P<0.01),且疗效随疗程增加而增加(P<0.01),平均透析间期体重增加相对值明显下降(P<0.01),且疗效随疗程增加而增大(P<0.01),口渴强度评分与透析间期体重增加相对值呈正相关(P<0.01)。结论:耳针压丸联合口嚼枸杞子能改善维持性血液透析患者的口渴症状,控制透析间期体重增加,且疗效随疗程增加而增大,而且口渴强度评分与透析间期体重增加相对值呈正相关,这为减少心脑血管并发症、改善患者生活质量提供了一种安全、简便、有效的治疗方法,值得临床推广与应用。
Objective：To evaluate the clinical therapeutic effect of ear pills combined with medlar treating hemodialysis patients with thirst.Methods：Fifty thirst disease patients receiving maintenance hemodialysis were given treatment of ear pills combined with chewed medlar for 8 weeks.Thirst scale was used to evaluate the thirsty degree,weight gained during average dialysis phase was recorded,the correlation between thirsty strength grading period with the mean arterial pressure before dialysis,relative weight gain,serum concentra-tion before dialysis were taken.The change of evaluation of thirst degree,the weight gain during dialysis period,blood pressure and serum before hemodialysis before treatment and 4 weeks and 8 weeks after treatment were collected.Results：After 2 courses of treatment,the thirst scores of the 50 patients before treatment were significantly decreased （P〈0.01）,and the curative effect was increased with the increase of treatment courses （P〈0.01）;the average weight gain significantly decreased （P〈0.01）,and the curative effect was in-creased with the increase of treatment courses （P〈0.01）;thirst score during dialysis and relative weight gain were positively correlated （P〈0.01）.Conclusion：Ear pills combined with chewed medlar can improve the symptoms of maintenance hemodialysis patients with thirst,control weight gain during dialysis period,and the curative effect increases with the increase of treatment courses.The thirst degree and the relative weight gain are positively correlated.It provides a safe,simple and effective treatment method to reducing cardiovascular complications and improving patients＇quality of life,and it is worthy of clinical popularization and application.
出处
《世界中医药》
CAS
2014年第6期750-753,共4页
World Chinese Medicine
基金
北京中医药大学校级自主选题项目(编号:2013-JYB22-XS-137)
